Princeton Global Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124K | Sell |
565
-425
| -43% | -$93K | 0.02% | 223 |
|
|
2025
Q1 | $222K | Sell |
990
-1,517
| -61% | -$340K | 0.04% | 178 |
|
|
2024
Q4 | $821K | Sell |
2,507
-100
| -4% | -$32.8K | 0.15% | 108 |
|
|
2024
Q3 | $783K | Sell |
2,607
-433
| -14% | -$130K | 0.15% | 107 |
|
|
2024
Q2 | $1M | Buy |
3,040
+299
| +11% | +$98.5K | 0.22% | 81 |
|
|
2024
Q1 | $1.08M | Sell |
2,741
-734
| -21% | -$290K | 0.26% | 76 |
|
|
2023
Q4 | $1.22M | Hold |
3,475
| – | – | 0.31% | 75 |
|
|
2023
Q3 | $1.3M | Buy |
3,475
+1,600
| +85% | +$600K | 0.37% | 71 |
|
|
2023
Q2 | $717K | Sell |
1,875
-1,600
| -46% | -$612K | 0.21% | 90 |
|
|
2023
Q1 | $1.2M | Hold |
3,475
| – | – | 0.35% | 72 |
|
|
2022
Q4 | $818K | Hold |
3,475
| – | – | 0.26% | 85 |
|
|
2022
Q3 | $855K | Hold |
3,475
| – | – | 0.3% | 79 |
|
|
2022
Q2 | $1.05M | Sell |
3,475
-75
| -2% | -$22.7K | 0.34% | 76 |
|
|
2022
Q1 | $1.46M | Hold |
3,550
| – | – | 0.4% | 70 |
|
|
2021
Q4 | $1.67M | Sell |
3,550
-150
| -4% | -$70.4K | 0.47% | 67 |
|
|
2021
Q3 | $1.57M | Buy |
3,700
+200
| +6% | +$84.9K | 0.48% | 64 |
|
|
2021
Q2 | $1.26M | Hold |
3,500
| – | – | 0.38% | 74 |
|
|
2021
Q1 | $986K | Buy |
3,500
+225
| +7% | +$63.4K | 0.32% | 85 |
|
|
2020
Q4 | $928K | Hold |
3,275
| – | – | 0.32% | 83 |
|
|
2020
Q3 | $900K | Sell |
3,275
-770
| -19% | -$212K | 0.36% | 79 |
|
|
2020
Q2 | $918K | Hold |
4,045
| – | – | 0.29% | 103 |
|
|
2020
Q1 | $616K | Buy |
4,045
+270
| +7% | +$41.1K | 0.27% | 105 |
|
|
2019
Q4 | $567 | Buy |
3,775
+250
| +7% | +$38 | 0.23% | 104 |
|
|
2019
Q3 | $493K | Hold |
3,525
| – | – | 0.28% | 98 |
|
|
2019
Q2 | $441K | Hold |
3,525
| – | – | 0.26% | 103 |
|
|
2019
Q1 | $388K | Hold |
3,525
| – | – | 0.27% | 96 |
|
|
2018
Q4 | $346K | Buy |
+3,525
| New | +$346K | 0.31% | 87 |
|